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Background: The relative incidence and clinical impact of individual respiratory viruses remains unclear among
children presenting to the hospital emergency department with acute respiratory tract infection (ARTI).
Methods: During two winter periods, respiratory virus real-time multiplex PCR results were evaluated from children
(< 18 years) presenting to the emergency department of a tertiary referral hospital with ARTI that had been sampled
within 48 hours of hospital presentation. In an attempt to identify virus-specific distinguishing clinical features, single
virus infections were correlated with presenting signs and symptoms, clinical findings and outcomes using multivariate
logistic regression.
Results: In total, 274 children with ARTI were evaluated and most were aged < 3 years (236/274, 86%). PCR detected
respiratory viruses in 224/274 (81.8%) children and included 162 (59%) single and 62 (23%) mixed virus infections.
Respiratory syncytial virus (RSV) and human rhinovirus (HRV) single virus infections were common among children
aged < 3 years, but proportional differences compared to older children were only significant for RSV (95% CI 1.3? 15).
Clinical differentiation between viral ARTIs was not possible due to common shared presenting signs and symptoms
and the high frequency of mixed viral infections. We observed virus-associated outcome differences among children
aged < 3 years. Oxygen treatment was associated with RSV (OR 3.6) and inversely correlated with FLU (OR 0.05).
Treatment with steroids (OR 3.4) or bronchodilators (OR 3.4) was associated with HRV. Severe respiratory complications
were associated with HRV (OR 3.5) and inversely correlated with RSV (OR 0.24).
Conclusions: Respiratory viruses are frequently detected in young children presenting to the hospital emergency
department with ARTI and require PCR diagnosis since presenting signs and symptoms are not discriminant for a type
of virus. RSV and HRV bear a high burden of morbidity in the pediatric clinical setting.
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Children suffer through multiple episodes of viral acute
respiratory tract infection (ARTI) annually and symptoms
range from common mild upper respiratory illness to
lower respiratory tract infection (LRTI) [1,2]. Large-scale
studies during the past decades were unable to provide ac-
curate virus-specific clinical correlations due to the low
sensitivity of viral culture and immunofluorescence tech-
niques and inability of these diagnostic methods to detect
non-culturable or mixed viral infections [1,3]. The routine
implementation of multiplex PCR in recent years has
allowed for sensitive and accurate identification of single
and mixed viral infections. [4,5].
The burden of individual respiratory viruses remains un-
clear among different pediatric age-groups in the clinical
setting. Recent molecular population-based studies show
that viral ARTIs exceed 21% of pediatric emergency de-
partment visits during the seasonal influenza winter season
and annual hospitalization rates exceed 1.5 per 100 chil-
dren aged < 3 years [6-8]. These findings suggest a high
burden of viral ARTI in young children. The burden of
viral respiratory pathogens in children is underestimated
since human rhinovirus (HRV) infections were not evalu-
ated in these studies. Recent clinical studies have included
HRV molecular diagnostics, but interpretation of virus-
associated correlations is hampered by age- and symptom-
related enrollment differences [9,10] or by sampling during
the 2009 influenza pandemic [11,12].
This study assessed the relative incidence of respiratory
virus infections in children presenting to the emergency
department of a tertiary hospital with ARTI during two
winter seasons and evaluated virus-specific clinical corre-
lations in young children.Methods
Study design and patient populations
This retrospective cohort study included all children
aged < 18 years presenting to the emergency department
of Leiden University Medical Center (LUMC) during the
2006 and 2007 winter seasons (November-April) with
ARTI who were sampled within 48 hours of hospital
presentation. The LUMC is a tertiary referral hospital
for the south-western part of the Netherlands covering a
population of approximately 2 million inhabitants. Clin-
ical diagnosis of ARTI was made by the attending phys-
ician. Routine diagnostic specimens were prospectively
analysed by respiratory virus multiplex PCR to evaluate
the relative incidence of respiratory viruses among different
pediatric age-groups (children aged < 3 years and children
aged 3? 17 years). Structured medical records of children
aged < 3 years with single virus infections (RSV, HRV, FLU
or Other) were evaluated for baseline characteristics, pre-
senting signs and symptoms and clinical outcomes.Respiratory specimens and molecular diagnostics
Qualified medical personnel obtained diagnostic re-
spiratory specimens and a single specimen was evalu-
ated for each child sampled within 48 hours of hospital
presentation. Respiratory specimens included nasopha-
ryngeal washes, throat swabs, nasal swabs, sputum or
tracheal aspirates. Nucleic acid was extracted by using
a MagnaPure LC total nucleic acid kit (Roche Diagnos-
tics, Mannheim, Germany) as described [4]. A fixed
amount of equine arteritis virus served as an RNA internal
control and phocid herpesvirus was used as a DNA in-
ternal control. Respiratory virus multiplex PCR detected
respiratory syncytial virus (RSV), human rhinovirus (HRV),
influenzavirus (FLU) A/B, parainfluenzavirus (PIV) 1/2/3/
4, human metapneumovirus (HMPV), human coronavirus
(HCoV) 229E/NL63/OC43, and adenovirus (HAdV) in
multiple tubes as described [4]. Primers, probes and ampli-
fication methods of the multiplex PCR used in this study
are described in reference 4 for ? laboratory 2? . In a pilot
run during the 2007 winter season, we performed add-
itional real-time PCR analysis of HCoV HKU1, Myco-
plasma pneumoniae and Chlamydophila pneumoniae [4].
During this pilot run, we performed additional analysis of
human bocavirus (HBoV) by real-time PCR amplification
of a 138-bp fragment of the NS1 gene as described by
others [13].Ethics
The study was conducted in accordance with ethical princi-
ples expressed in the World Medical Association? s Declar-
ation of Helsinki. The study procedures complied with legal
and regulatory standards and clinical data was obtained by
following professional codes of conduct. All necessary pre-
cautions were taken to prevent identification of any child
included in the study. The Medical Ethics Committee
(MEC) of Leiden University Medical Center reviewed the
study protocol (C14.128) and final version of the manu-
script and confirms that the study is based on clinical data
collected in the context of routine clinical practice. For this
retrospective analysis of routine clinical data the committee
declares that no formal ethical approval and written in-
formed consent is needed.Study procedure
Viral distribution
Routine diagnostic PCR results from all eligible children
were analysed. Distribution of RSV, HRV, FLU and Other
single virus infections was depicted by age-groups (young
children aged < 3 years and children aged 3? 17 years).
PIV, HMPV, HAdV and HCoV were aggregated into a dis-
tinct group (Other) due to small numbers and to enable
more accurate comparative virus-associated correlations.
Figure 1 Viral etiologies of 274 children with ARTI presenting
to the emergency department of a tertiary referral hospital.
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The attending physician recorded signs and symptoms
of young children aged < 3 years using structured med-
ical records. Presenting signs and symptoms manifesting
within 48 hours of hospital presentation of children with
RSV, HRV, FLU or Other single virus infections were
evaluated. Virus-associated symptoms were compared
and included fever > 38.5?C, cough, rhinitis, pharyngitis,
wheezing, crepitations, dyspnea or tachypnea. The clin-
ical presence of chest wall retractions, nasal flaring,
moaning or laboured breathing were used to define dys-
pnea. World Health Organization clinical diagnostic cri-
teria defined tachypnea among children aged < 2 months
(≥ 60 breaths per minute, bpm), aged 2 to 12 months
(≥ 50 bpm) and aged ≥ 12 months (≥ 40 bpm).
Outcomes
The attending physician recorded outcomes of children
aged < 3 years with RSV, HRV, FLU and Other single
virus infections. We evaluated laboratory and pulmonary
imaging findings that were obtained within 96 hours of
hospital presentation and adverse outcome manifestations
(hospital admission, severe respiratory complications, mor-
tality) that were recorded within ≤ 7 days of hospital pres-
entation. Laboratory findings included C-reactive protein
(CRP) and white blood cell count (WBC). We evaluated
cut-offs that would indicate absence of serious bacterial
infections (CRP < 35 mg/l; WBC < 15 x109/L) [14,15].
We compared bacteriology results that were obtained by
PCR (atypical bacteria) or from routine cultures from
non-sterile (urine, sputum) and sterile sites (blood, cere-
brospinal fluid). Pulmonary imaging findings were
assessed for signs of LRTI (radiologic presence of alveo-
lar or peribronchial infiltrates, interstitial opacities,
hyperinflation). Supplemental treatments included bro-
chodilators, steroids, oxygen supplementation and anti-
biotics. Oxygen supplementation was provided during
sustained oxygen saturation ≤ 92% or during dyspnea
with abnormal PCO2 levels. Adverse outcomes included
hospital admission, development of severe respiratory
complications and all-cause mortality ≤ 7 days of hospital
presentation. Severe respiratory complications were de-
fined as apnea, respiratory intubation and Apparent Life
Threatening Events (ALTE). ALTE was defined as an
acute change in an infant ? s breathing behavior perceived
as possibly life threatening by the child ? s caretaker.
Statistical analysis
Statistical analyses were performed using SPSS software
version 20.0 (SPSS, Chicago, IL). Continuous variables
were presented as mean or median (with range) and cat-
egorical variables as frequencies (with percentages).
Mann ? Whitney U-test and Kruskal? Wallis test were
used as non-parametric tests to compare age (months)between 2 or more groups, because of non-normally dis-
tributed data. Chi square was performed to compare cat-
egorical variables between 2 groups. Logistic regression
analysis compared categorical variables between virus
groups including presenting signs and symptoms, diag-
nostic, treatment and outcome findings. Multivariate
analyses adjusted for age, gender and relevant history or
chronic underlying disorders (stepwise). A 2-sided value
of P < 0.05 was considered significant.
Results
Patient enrollment and viral etiology
During two winter seasons, we enrolled 274 children
presenting to the emergency department with ARTI and
sampled within 48 hours of hospital presentation. The
majority of children were aged < 3 years (236/274, 86%)
compared to older children aged 3? 17 years (38/274,
14%). Multiplex PCR detected respiratory viruses in 82%
(224/274) of all children and included single virus infec-
tions (162 of 224, 72%) and mixed viral infections (62 of
224, 28%) (Figure 1). Single virus infections were caused
by RSV (69 of 224, 31%), HRV (53 of 224, 24%), FLU (16
of 224, 7%) and Other (24 of 224, 11%). In a pilot run
among a total 131 children during the 2007 winter sea-
son, PCR yielded HBoV (7%) and HCoV HKU1 (1%),
but no Mycoplasma pneumoniae and Chlamydophila
pneumoniae. HBoV- and HCoV HKU1-associated clin-
ical findings were not evaluated due to a rare occurrence
of single virus infections (n = 4 HBoV; n = 0 HCoV
HKU1) and due to incomplete data (single season).
Respiratory virus distribution
The distribution of single virus infections among different
age groups was evaluated in an attempt to establish virus-
associated clinical correlations. Mixed viral infections were
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culty to establish clinical relevance. Single virus infections
were common among young children aged < 3 years (144
of 236, 61%) compared to older children (18 of 38, 47%)
but these proportional differences were not statistically
significant (Figure 2). RSV and HRV were more common
among children aged < 3 years compared to older children,
but proportional differences were only significant for RSV
(28% vs 7.9%; 95% CI 1.3? 15). In contrast, young children
were less common infected with Other single viruses (in-
cluding PIV, HMPV, HAdV or HCoV) compared to older
children (7.2% vs 18%; 95% CI 0.13? 0.90). FLU single virus
infections were uncommon in both age groups with a
similar low prevalence (range, 5 to 11%).Virus-specific clinical correlations
Baseline characteristics
Evaluation of baseline characteristics was limited to chil-
dren aged < 3 years with single virus infections (RSV, HRV,
FLU, Other ) with clinical data available. We included
demographics (sex, age) and relevant history encompassing
prematurity at birth (gestational age < 37 weeks), bronchial
hyperreactivity (bronchoconstriction in response to stim-
uli) and underlying pulmonary, cardiovascular and im-
munodeficiency disorders. Base-line characteristics were
equally distributed among virus groups, except for a male
predominance (Table 1) among children with HRV vs FLU
(73% vs 36%; 95% CI 1.2? 19). Proportional differences at
baseline underscore the need for statistical adjustment for
possible confounders during comparative analyses.Signs and symptoms
Presenting signs and symptoms were compared among







































   
   
  
Figure 2 Distribution of single respiratory virus infections among diffand clinical data available (Table 1, Figure 3). Six children
were previously excluded from comparative analyses due
to incomplete documentation. Children aged 3? 17 years
were not evaluated due to small numbers and age-related
confounding differences. Multivariate analyses adjusted
for possible confounders including age and sex, and step-
wise for relevant underlying disorders. Significant virus-
associated presenting signs and symptoms (Figure 3)
included fever (FLU vs RSV, P = 0.01; FLU vs HRV, P =
0.01), cough (RSV vs FLU, P = 0.02; RSV vs Other, P =
0.03), crepitations (RSV vs HRV, P = 0.02), dyspnea and
tachypnea (RSV vs FLU, P = 0.04).Clinical outcomes
Clinical outcomes were compared among 123 children
aged < 3 years with single virus infections and clinical
data available (Table 1, Table 2). A total of 21 children
were previously excluded from comparative analyses
due to incomplete documentation or hospital transfer
without follow-up data. Excluded cases were equally
distributed among virus groups (Table 1). High levels of
CRP (≥ 35 mg/l) or WBC (≥ 15 x109/L) and antibiotic
treatment were equally distributed among virus groups
and suggested no differences in potential serious bac-
terial infections. Bacterial cultures and PCRs were often
negative and were equally distributed among individual
virus infections. This supports the assumption that
there were no differences in potential serious bacterial
infections among virus groups. Hospital admission
(~80%) was equally distributed and fortunately there
was no mortality. Overall and individual comparisons
were made among children with RSV, HRV, FLU and
Other single virus infections (Table 2) following multi-








Age 3-17 years (n=38 children evaluated)
erent pediatric age groups.
Table 1 Baseline characteristics of children aged < 3 years with single respiratory virus infections
Total RSV HRV FLU Other
N (%) N (%) N (%) N (%) N (%)
Children <3 y with single virus ARTI
Total included 144 66 49 12 17
Analysis of signs and symptoms (data available) 138 64 46 11 17
Analysis of clinical outcomes (data available) 123 53 44 11 15
Demographics (analysis of clinical outcomes)
Male 76 (62) 30 (57) 32 (73)$ 4 (36)$ 10 (67)
Mean age, months [range] 8 [0? 35] 7 [0? 35] 7 [0? 24] 10 [1? 26] 11 [0? 33]
Median age, months [range] 4 [0? 35] 3 [0? 35] 4 [0? 24] 9 [1? 26] 8 [0? 33]
Clinical history (analysis of clinical outcomes)
Prematurity at birth 11 (9) 6 (11) 3 (7) 1 (9) 1 (7)
History of BHR 12 (9) 5 (9) 5 (11) 1 (9) 1 (7)
Chronic pulmonary disorder 2 (2) 0 2 (5) 0 0
Chronic cardiovascular disorder 12 (10) 3 (6) 6 (14) 1 (9) 2 (13)
Chronic immunodeficiency disorder 5 (4) 0 2 (5) 1 (9) 2 (13)
Baseline characteristics are equally distributed, except for a male predominance with HRV vs FLU (95%CI 1.2-19)$.
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Overall, RSV infection was associated with supplemental
oxygen requirement (OR 3.6) and inversely correlated
with severe respiratory complications (OR 0.24). Individ-
ual comparisons revealed that RSV was associated with
supplemental oxygen requirement compared to FLU (OR
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Figure 3 Signs and symptoms of 138 children aged < 3 years present
with single virus ARTI. The proportions of presenting signs and symptoms
and multivariate adjustment for demographics and relevant clinical history (st
groups are depicted and include fever (FLU vs RSV, P = 0.01; FLU vs HRV, P = 0HRV
Overall, HRV infection was associated with bronchodilator
therapy (OR 3.0), steroid treatment (OR 3.4) and severe re-
spiratory complications (OR 3.5). Individual comparisons
revealed that HRV was associated with bronchodilator ther-
apy compared to Other (OR 7.0), steroid treatment com-
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is Wheezing Crepitations Dyspnea Tachypnea
RSV .01 
HRV .01 
ing to the emergency department of a tertiary referral hospital
were compared between virus groups using logistic regression analysis
epwise). Significant proportional differences (P < 0.05) between virus
.01) and other findings (cough, crepitations, dyspnea and tachypnea).
Table 2 Outcomes associated with single respiratory virus infections in children aged < 3 years
Single virus ARTI Statistical analysis
Total RSV HRV FLU Other vs Multivariate$ P
N (%) N (%) N (%) N (%) N (%) OR (95%CI) value
Diagnostics
Chemistry/hematology
CRP≥ 35 mg/L 28/81 (35) 11/32 (34) 11/29 (38) 2/9 (22) 4/11 (36) ? ? NS
WBC≥ 15 x109/L 27/80 (34) 11/32 (34) 11/28 (39) 2/9 (22) 3/11 (27) ? ? NS
Bacteriology NS
PCR atypical bacteria 0/10 (0) 0/2 (0) 0/4 (0) 0/1 (0) 0/3 (0) ? ? NS
Culture, sterile site 2/45 (4) 0/15 (0) 1/17 (6) 0/7 (0) 1/6 (17) ? ? NS
Culture, non-sterile site 1/19 (5) 0/7 (0) 0/8 (0) 0/1 (0) 1/3 (33) ? ? NS
Pulmonary imaging
LRTI# 31/63 (37) 15/24 (63) 10/25 (40) 3/6 (33) 3/8 (38) ? ? NS
Treatment
Antibiotics 50/122 (41) 24/53 (45) 17/43 (40) 3/11 (27) 6/15 (40) ? ? NS
Bronchodilators 31/113 (27) 12/48 (25) 15/39 (38) 2/11 (18) 2/15 (13) HRV vs Other 7.0 (1.2-42) .03
HRV overall 3.0 (1.2-7.8) .02
Steroids 26/117 (22) 8/52 (15) 13/39 (33) 2/11 (18) 3/15 (20) HRV vs RSV 3.5 (1.2-11) .03
HRV overall 3.4 (1.2-9.3) .02
Oxygen therapy 67/118 (57) 38/52 (73) 22/41 (54) 1/10 (10) 6/15 (40) RSV vs FLU 26 (3.0-225) < .01
RSV vs Other 4.2 (1.3-14) .02
HRV vs FLU 11 (1.2-97) .03
RSV overall 3.6 (1.6-8.0) < .01
FLU overall .05 (.01-.40) < .01
Adverse outcome
Hospital admission 99/123 (80) 46/53 (87) 33/44 (75) 8/11 (73) 12/15 (80) ? ? NS
Severe respiratory complication 15/123 (12) 3/53 (6) 9/44 (20) 1/11 (9) 2/15 (13) HRV vs RSV 5.0 (1.2-21) .03
HRV overall 3.5 (1.0-11) .04
RSV overall .24 (.06-.92) .04
Apnea 5/123 (4) 1/53 (2) 4/44 (9) 0/11 (0) 0/15 (0) ? ? NS
Intubation 7/123 (6) 1/53 (2) 5/44 (11) 0/11 (0) 1/15 (7) ? ? NS
ALTE 6/123 (5) 1/53 (2) 3/44 (7) 1/11 (9) 1/15 (7) ? ? NS
Mortality≤ 7 days 0/123 (0) 0/53 (0) 0/44 (0) 0/11 (0) 0/15 (0) ? ? NS
ARTI, Acute Respiratory Tract Infection, CRP, C-reactive protein; WBC, White Blood Cell count; LRTI, lower respiratory tract infection; ALTE, Apparent Life Threatening
Events; NS, not significant.
#LRTI was defined as radiologic presence of alveolar infiltrates, interstitial opacities, peribronchial infiltrates or hyperinflation.
$Multivariate correction for sex, age and underlying disease (forward stepwise adjustment) using logistic regression analysis.
Gooskens et al. BMC Pediatrics 2014, 14:297 Page 6 of 9
http://www.biomedcentral.com/1471-2431/14/297compared to FLU (OR 11) and severe respiratory compli-
cations (apnea, respiratory intubation or ALTE) compared
to RSV (OR 5.0). HRV subtyping was not performed and
therefore specific subtypes could not be associated with
clinical outcome.
FLU
Overall, Flu infection was inversely correlated with supple-
mental oxygen requirement (OR 0.05). Individual compar-
isons revealed no FLU specific outcome associations.Discussion
This study confirmed a frequent viral etiology among
82% (224 of 274) of children aged < 18 years presenting
to the emergency department of a tertiary hospital with
ARTI. These findings add to a growing body of literature
on the epidemiology and virus-associated clinical fea-
tures in the clinical setting [6-12].
The high detection rate of respiratory viruses using
multiplex PCR was similar to previously published rates
exceeding 80% in the pediatric clinical setting [10,11].
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other studies are likely due to age- and symptom-related
enrollment differences or due to sampling during non-
winter seasons [9,12]. A high rate of mixed viral infec-
tions in this study (23%) is similar to findings in other
studies (range 14% - 30%) [9-11].
Children presenting to the hospital emergency depart-
ment with ARTI and sampled within 48 hours were pre-
dominantly aged < 3 years (236 of 274, 86%). HRV and
RSV single virus infections were common among chil-
dren aged < 3 years, but proportional differences com-
pared to older children were only significant for RSV
(95% CI 1.3 ? 15). Previous studies report a similar pre-
dominance of RSV among young children in the clinical
setting [7,8,10] but reports on HRV age-distribution are
mixed [10,16]. FLU cases were often young children
(n = 12) compared to older children (n = 4) but the small
numbers and the lack of a population-based design re-
strict firm epidemiologic conclusions.
Viral ARTI signs and symptoms are widely presumed
to be aspecific but confirmation of this assumption is
lacking. This study confirmed that viral ARTI presenting
signs and symptoms are aspecific by comparative statis-
tical analysis among children aged < 3 years with single
virus infections. Fever was often associated with influ-
enza (FLU vs RSV, P = 0.01; FLU vs HRV, P = 0.01) and
cough was often associated with RSV (RSV vs FLU, P =
0.02; RSV vs Other, P = 0.03). Unfortunately, these and
other findings were insufficient to differentiate between
individual viral ARTIs due to common shared signs and
symptoms among viruses and the high frequency of
mixed viral infections [9]. A febrile disease with ARTI
symptoms was observed among ≥ 25% of total viruses in-
fections, therefore influenza-like illness required PCR
confirmation to establish FLU diagnosis [17,18].
Virus-specific comparative outcome analysis among
children aged < 3 years with single virus infections un-
veiled clinical outcome similarities (Table 2). Laboratory
infection parameters (CRP, WBC), pulmonary imaging
LRTI findings and antibiotic use were similar among
virus groups. The findings contrast with a previous study
which reported high CRP levels, elevated leucocyte
counts and frequent antibiotic use during HRV [10]. In
this study, children with RSV often received antibiotics
(45%). Previous studies show that rapid confirmation of
RSV can limit antibiotic use [19,20], but antibiotic stew-
ardship guided by respiratory virus PCR results may be
difficult to implement [21].
Relevant virus-specific outcome differences include sup-
plemental oxygen treatment requirement (RSV), steroid
and bronchodilator treatment (HRV) and development of
severe respiratory complications (HRV). Supplemental
treatments with corticosteroids and bronchodilators were
remarkably associated with HRV. There is insufficientevidence on the benefit of corticosteroids or bronchodila-
tors during viral LRTI and most guidelines do not recom-
mend the routine use for cases of RSV LRTI [22].
However, corticosteroids may improve HRV-induced
wheezing and bronchodilators may be effective for individ-
ual children experiencing LRTI with underlying reactive-
airway disease. This may explain why corticosteroids and
bronchodilators were more commonly provided to chil-
dren with HRV. Young children presenting to the hospital
emergency department with the combined symptoms of
cough, pulmonary crepitation and oxygen-dependent viral
LRTI were more likely to be infected with RSV than with
other viruses as reported by others [12,23]. With the know-
ledge that RSV is more often associated with oxygen-
dependent viral LRTI, it would seem counter-intuitive that
HRV (and not RSV) is associated with more severe respira-
tory complications (Table 2). HRV often causes mild symp-
toms, but the findings of this and other studies suggest
that the occurrence of severe HRV respiratory complica-
tions may be underestimated [24,25]. In this study, FLU in-
fection was inversely correlated with supplemental oxygen
treatment compared to other infections as described by
others [26]. We emphasize that the low number of FLU
cases does not allow for any firm conclusions on this mat-
ter. Previous studies suggest that FLU manifestations may
be relatively mild among young children presenting to the
hospital during seasonal influenza, but rare life-threatening
events and severe cases of concomitant bacterial pneumo-
nia do occur [12,27].
Limitations
Children were evaluated at a tertiary care setting and
this possibly limits the validity of virus-specific clinical
correlations in other settings. The retrospective design
of the study and evaluation of the patients by different
attending physicians may have introduced a reporting
bias. The inclusion of children sampled within 48 hours
of hospital presentation may have introduced a selection
bias towards younger patients due to a more cautious clin-
ical and diagnostic approach of parents and paediatricians
in that age group [28]. This could explain why the major-
ity of children included in this study were aged < 3 years
(236/274, 86%).
The respiratory specimens were of different types (in-
cluding nasopharyngeal washes, throat swabs, nasal swabs,
sputum or tracheal aspirates) which could have bearing on
the sensitivity of the PCR for the various viruses and thus
their ? relative frequency? . The number of children with
viral ARTI is an underestimation since our multiplex PCR
did not detect HBoV, HCoV HKU1, human influenza C
virus and enteroviruses that may cause viral respiratory in-
fections. Molecular differentiation of HRV and enterovi-
ruses is difficult and the HRV assay used in this study
cross-reacts with a few enteroviruses that are associated
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may explain severe ?HRV ? infections and emphasizes that
future studies should elucidate the specific role of HRV
and enteroviruses using molecular subtyping.
In this study, multiple comparisons were performed
which can lead to more type I errors (more false posi-
tives) since 5% of the comparisons have uncorrected
P values < 0.05. Statistical adjustment of confidence in-
tervals (eg Bonferroni corrections) can be applied to re-
duce incorrect rejection of true null hypotheses and to
lower type I errors, but these corrections can increase
the type II error (more false negatives) and lead to inter-
pretation errors [29]. In this observational study, no ad-
justments were made for multiple comparisons in an
attempt to find novel virus-specific clinical correlations.
This approach is intended for hypothesis generation and
not for hypothesis testing. Future prospective studies
using improved standardized study protocols are there-
fore awaited to confirm virus-associated clinical findings
and for hypothesis testing.Conclusions
This study confirmed that a viral agent is frequently
found in young children with ARTI presenting to the
pediatric emergency department of a tertiary referral
hospital. Molecular diagnostics are required to confirm
respiratory virus infections since presenting symptoms
could not discriminate between the viruses. RSV and
HRV infections bear the highest burden of morbidity in
the pediatric clinical setting.Abbreviations
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